IP Verse

Stable Liquid Fibrinogen

Patent No. EP3481415 (titled "Stable Liquid Fibrinogen") was filed by Laboratoire Franais DU Fractionnement ET DES Biotechnologies on Jul 6, 2017. The application was issued on Sep 6, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BIOTESTJun 5, 2024TER MEER STEINMEISTER & PARTNER
TAKEDA PHARMACEUTICALSJun 5, 2024HOFFMANN EITLE
MARCHANTMay 24, 2024MURGITROYD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3481415

LABORATOIRE FRANAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Application Number
EP17742825A
Filing Date
Jul 6, 2017
Status
Granted And Under Opposition
Aug 4, 2023
Publication Date
Sep 6, 2023
External Links
Slate, Register , Google Patents